Hedge Fund Wagers Million on Biotech After FDA Milestone
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesA major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
Two very different apparel plays: FIGS targets a niche medical market with growth potential, while Gildan Activewear ...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
Two AI-era stock stories headline this guide: Palantir as an undervalued growth play and Sandisk as a growth leader w...
NVIDIA stock has dipped below $200 again, prompting questions about its upside. This article breaks down the catalyst...
In the first half of 2026, silver moved in two dramatic acts: a rapid ascent followed by a sharp pullback. This artic...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
Broadcom sits at the crossroads of AI infrastructure and traditional networking. Here are three grounded predictions ...
NRG Energy surges to the lead in 2025, driven by Larry Coben’s leadership and a strategy to pair robust gas-fired gen...
A stock that looks dirt cheap can spark big dreams of rapid gains. Before you chase an 83% rally, learn a practical f...
Broadcom stock rallied Thursday as AI-driven demand for semiconductor hardware pushed shares higher. This article bre...